ClinVar Miner

Submissions for variant NM_002485.4(NBN):c.1036G>A (p.Val346Met) (rs200297914)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000212741 SCV000149685 uncertain significance not specified 2017-07-24 criteria provided, single submitter clinical testing This variant is denoted NBN c.1036G>A at the cDNA level, p.Val346Met (V346M) at the protein level, and results in the change of a Valine to a Methionine (GTG>ATG). This variant was reported in an individual with breast cancer and another with endometrial cancer undergoing multigene hereditary cancer testing (Tung 2016, Ring 2016). NBN Val346Met was not observed at significant allele frequency in 1000 Genomes. Since Valine and Methionine share similar properties, this is considered a conservative amino acid substitution. NBN Val346Met occurs at a position that is not conserved and is located in the region of interaction with MTOR, MAPKAP1, and RICTOR (Wang 2013, UniProt). In silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. Based on currently available evidence, it is unclear whether NBN Val346Met is pathogenic or benign. We consider it to be a variant of uncertain significance.
Ambry Genetics RCV000115776 SCV000186073 uncertain significance Hereditary cancer-predisposing syndrome 2018-05-08 criteria provided, single submitter clinical testing Insufficient or conflicting evidence
Invitae RCV000589164 SCV000261858 likely benign not provided 2019-03-01 criteria provided, single submitter clinical testing
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000589164 SCV000341709 uncertain significance not provided 2016-04-27 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000589164 SCV000697932 uncertain significance not provided 2016-02-23 criteria provided, single submitter clinical testing
Color RCV000115776 SCV000902682 likely benign Hereditary cancer-predisposing syndrome 2015-11-18 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000589164 SCV001134492 likely benign not provided 2019-04-18 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.